{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:42:53Z","timestamp":1792698173029,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2018-12365734"],"award-info":[{"award-number":["GR-2018-12365734"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FIS_00001711"],"award-info":[{"award-number":["FIS_00001711"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RF-2016-02362055"],"award-info":[{"award-number":["RF-2016-02362055"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bpg.2024.101924","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T23:25:37Z","timestamp":1715210737000},"page":"101924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2670-3922","authenticated-orcid":false,"given":"Sandra","family":"Garcia-Mateo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Rondinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Ponziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cammarota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Lanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gomoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2024.101924_bib1","series-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature Authors","author":"Rinella","year":"2023"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2024.101924_bib3","article-title":"Inflammatory bowel disease is an independent risk factor for metabolic dysfunction\u2013associated steatotic liver disease in lean individuals","author":"Mart\u00ednez-Dom\u00ednguez","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2024.101924_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Therapeut"},{"issue":"6","key":"10.1016\/j.bpg.2024.101924_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol [Internet]"},{"issue":"3","key":"10.1016\/j.bpg.2024.101924_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jhep.2013.10.034","article-title":"Mediterranean diet and hepatocellular carcinoma","volume":"60","author":"Turati","year":"2014","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.bpg.2024.101924_bib7","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/ATVBAHA.111.228262","article-title":"Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation","volume":"31","author":"Ndumele","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.bpg.2024.101924_bib8","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?","volume":"158","author":"Aron-Wisnewsky","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bpg.2024.101924_bib9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.bpg.2024.101924_bib10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.bpg.2024.101924_bib11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI21047","article-title":"Splanchnic lipolysis in human obesity","volume":"113","author":"Nielsen","year":"2004","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.bpg.2024.101924_bib12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2016.01.010","article-title":"Association of nonalcoholic fatty liver disease with visceral adiposity but not coronary artery clacification in the elderly","volume":"14","author":"Jacobs","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2024.101924_bib13","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bpg.2024.101924_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cmet.2012.03.007","article-title":"The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling","volume":"15","author":"Fu","year":"2012","journal-title":"Cell Metabol"},{"key":"10.1016\/j.bpg.2024.101924_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cld.2009.07.009","article-title":"Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis","volume":"13","author":"Cusi","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.bpg.2024.101924_bib16","series-title":"Advances in experimental medicine and biology","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","article-title":"Insulin resistance, obesity and lipotoxicity","author":"Yaz\u0131c\u0131","year":"2017"},{"issue":"2","key":"10.1016\/j.bpg.2024.101924_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.hepres.2005.09.020","article-title":"Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases","volume":"33","author":"Seki","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1016\/j.bpg.2024.101924_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.bpg.2024.101924_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-018-0061-2","article-title":"You are what you eat: diet, health and the gut microbiota","volume":"16","author":"Zmora","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7758","key":"10.1016\/j.bpg.2024.101924_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","article-title":"The integrative human microbiome project","volume":"569","author":"Proctor","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bpg.2024.101924_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu13020699","article-title":"Nutritional components in western diet versus mediterranean diet at the gut microbiota-immune system interplay. implications for health and disease","volume":"13","author":"Garc\u00eda-Montero","year":"2021","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bpg.2024.101924_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nri.2017.7","article-title":"Dysbiosis and the immune system","volume":"17","author":"Levy","year":"2017","journal-title":"Nat Rev Immunol [Internet]"},{"key":"10.1016\/j.bpg.2024.101924_bib23","first-page":"558","volume":"vol. 72","author":"Albillos","year":"2020"},{"issue":"4","key":"10.1016\/j.bpg.2024.101924_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bpg.2024.101924_bib25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bpg.2024.101924_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cmet.2009.09.006","article-title":"Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice","volume":"10","author":"Saberi","year":"2009","journal-title":"Cell Metabol"},{"issue":"6","key":"10.1016\/j.bpg.2024.101924_bib27","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.bpg.2024.101924_bib28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cmet.2015.07.026","article-title":"Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling","volume":"22","author":"Caesar","year":"2015","journal-title":"Cell Metabol"},{"key":"10.1016\/j.bpg.2024.101924_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bpg.2024.101924_bib30","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/gutjnl-2014-307913","article-title":"Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults","volume":"64","author":"Chambers","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","article-title":"Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis","volume":"40","author":"Singh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bpg.2024.101924_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/nu15092211","article-title":"Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota","volume":"15","author":"Fusco","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.bpg.2024.101924_bib33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41564-018-0150-6","article-title":"Microbiota-Accessible carbohydrates suppress Clostridium difficile infection in a murine model","volume":"3","author":"Hryckowian","year":"2018","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.bpg.2024.101924_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.bpg.2024.101924_bib35","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.bpg.2024.101924_bib36","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metabol"},{"issue":"3","key":"10.1016\/j.bpg.2024.101924_bib37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.31417","article-title":"Microbiomics, metabolomics, predicted metagenomics, and hepatic steatosis in a population-based study of 1,355 adults","volume":"73","author":"Alferink","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2024.101924_bib38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/dme.13565","volume":"35","author":"Sberna","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.bpg.2024.101924_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2019.06.001","article-title":"Benefits of the Mediterranean diet: epidemiological and molecular aspects","volume":"67","author":"Serra-Majem","year":"2019","journal-title":"Mol Aspect Med"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2223339","article-title":"Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis","volume":"15","author":"G\u00f3mez-P\u00e9rez","year":"2023","journal-title":"Gut Microb"},{"issue":"4","key":"10.1016\/j.bpg.2024.101924_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041013","article-title":"Leisure-time physical activity, sedentary behaviour and diet quality are associated with metabolic syndrome severity: the PREDIMED-plus study","volume":"12","author":"Gallardo-Alfaro","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bpg.2024.101924_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041133","article-title":"Twelve-week mediterranean diet intervention increases citrus bioflavonoid levels and reduces inflammation in people with type 2 diabetes mellitus","volume":"13","author":"Al-Aubaidy","year":"2021","journal-title":"Nutrients"},{"issue":"10338","key":"10.1016\/j.bpg.2024.101924_bib43","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial","volume":"399","author":"Delgado-Lista","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2024.101924_bib44","first-page":"829","volume":"vol. 67","author":"Romero-G\u00f3mez","year":"2017"},{"issue":"7","key":"10.1016\/j.bpg.2024.101924_bib45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.14309\/ajg.0000000000002098","article-title":"Exercise training is associated with treatment response in liver fat content by magnetic resonance imaging independent of clinically significant body weight loss in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"118","author":"Stine","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101924_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-023-00800-4","article-title":"Lifestyle interventions in nonalcoholic fatty liver disease","author":"Younossi","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2024.101924_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106903","article-title":"Physical activity and diet quality in relation to non-alcoholic fatty liver disease: a cross-sectional study in a representative sample of U.S. adults using NHANES 2017\u20132018","volume":"154","author":"Heredia","year":"2022","journal-title":"Prev Med"},{"key":"10.1016\/j.bpg.2024.101924_bib48","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cgh.2016.04.036","article-title":"Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression","volume":"14","author":"Orci","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2024.101924_bib49","article-title":"The role of diet in shaping human gut microbiota","volume":"vols. 62\u201363","author":"Rinninella","year":"2023"},{"issue":"4","key":"10.1016\/j.bpg.2024.101924_bib50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1249\/MSS.0000000000001495","article-title":"Exercise alters gut microbiota composition and function in lean and obese humans","volume":"50","author":"Allen","year":"2018","journal-title":"Med Sci Sports Exerc"},{"issue":"12","key":"10.1016\/j.bpg.2024.101924_bib51","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1136\/gutjnl-2013-306541","article-title":"Exercise and associated dietary extremes impact on gut microbial diversity","volume":"63","author":"Clarke","year":"2014","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bpg.2024.101924_bib52","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/ajcn\/nqac175","article-title":"Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial","volume":"116","author":"Seethaler","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bpg.2024.101924_bib53","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage. Vol. 8","author":"Mora","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpg.2024.101924_bib54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/10409238.2019.1611734","article-title":"Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis","volume":"54","author":"Cantorna","year":"2019","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"11","key":"10.1016\/j.bpg.2024.101924_bib55","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1136\/gutjnl-2020-323106","article-title":"Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT plus randomised controlled trial","volume":"70","author":"Meir","year":"2021","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-19753-9","article-title":"Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance","volume":"8","author":"Da Silva","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpg.2024.101924_bib57","first-page":"5","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpg.2024.101924_bib58","article-title":"Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?","author":"Portincasa","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib59","first-page":"1","article-title":"Physical activity and low glycemic index mediterranean diet: main and modification effects on NAFLD score. Results from a randomized clinical trial","volume":"13","author":"Franco","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2024.101924_bib60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nutres.2023.09.005","article-title":"Adherence to a Mediterranean diet may improve serum adiponectin in adults with nonalcoholic fatty liver disease: the MEDINA randomized controlled trial","volume":"119","author":"Reddy","year":"2023","journal-title":"Nutr Res"},{"issue":"2","key":"10.1016\/j.bpg.2024.101924_bib61","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S000711451800137X","article-title":"Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial","volume":"120","author":"Katsagoni","year":"2018","journal-title":"Br J Nutr"},{"issue":"15","key":"10.1016\/j.bpg.2024.101924_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/nu14153186","article-title":"Adherence to mediterranean diet and NAFLD in patients with metabolic syndrome: the FLIPAN study","volume":"14","author":"Montemayor","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16159-x","article-title":"Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: a randomized controlled trial","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib64","article-title":"A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib65","article-title":"A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.bpg.2024.101924_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091773","article-title":"A low glycemic index mediterranean diet combined with aerobic physical activity rearranges the gut microbiota signature in NAFLD patients","volume":"14","author":"Calabrese","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2223339","article-title":"Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis","volume":"15","author":"G\u00f3mez-P\u00e9rez","year":"2023","journal-title":"Gut Microb"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1210\/jc.2015-3351","article-title":"Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population","volume":"101","author":"Haro","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010033","article-title":"Preventive effect of spontaneous physical activity on the gut-adipose tissue in a mouse model that mimics Crohn\u2019s disease susceptibility","volume":"8","author":"Maillard","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.bpg.2024.101924_bib70","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/liv.14453","article-title":"Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"40","author":"Adams","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.bpg.2024.101924_bib71","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/hep.29892","article-title":"Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2024.101924_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158805","article-title":"The effects of probiotics, prebiotics and synbiotics in non-alcoholic fat liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review","volume":"23","author":"Carpi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bpg.2024.101924_bib73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajcn\/nqz042","article-title":"Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"110","author":"Sharpton","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bpg.2024.101924_bib74","first-page":"9","article-title":"Effect of probiotics on liver enzymes in patients with non-alcoholic fatty liver disease: an umbrella of systematic review and meta-analysis","author":"Musazadeh","year":"2022","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0035-1571276","article-title":"Targeting dysbiosis for the treatment of liver disease","volume":"36","author":"Anand","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2024.101924_bib76","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41575-020-00390-5","article-title":"The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on fermented foods","volume":"18","author":"Marco","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.bpg.2024.101924_bib77","article-title":"The effect of probiotics (Mcp\u00ae bcmc\u00ae strains) on hepatic steatosis, small intestinal mucosal immune function, and intestinal barrier in patients with non-alcoholic fatty liver disease","volume":"13","author":"Nor","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib78","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-021-01660-5","article-title":"A randomised placebo controlled trial of VSL#3\u00ae probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease","volume":"21","author":"Chong","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib79","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-021-01660-5","article-title":"A randomised placebo controlled trial of VSL#3\u00ae probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease","volume":"21","author":"Chong","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"10.1016\/j.bpg.2024.101924_bib80","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41591-022-01964-3","article-title":"Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases","volume":"28","author":"Ianiro","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.bpg.2024.101924_bib81","first-page":"9","article-title":"The use of faecal microbiota transplantation (FMT) in Europe: a Europe-wide survey","author":"Baunwall","year":"2021","journal-title":"Lancet Region Health - Europe"},{"issue":"8","key":"10.1016\/j.bpg.2024.101924_bib82","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/2050640618780762","article-title":"Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: a systematic review and meta-analysis","volume":"6","author":"Ianiro","year":"2018","journal-title":"Unit Europ Gastroenterol J"},{"issue":"9","key":"10.1016\/j.bpg.2024.101924_bib83","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/cid\/ciac207","article-title":"Cost-effectiveness of fecal microbiota transplantation for first recurrent Clostridioides difficile infection","volume":"75","author":"Aby","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.bpg.2024.101924_bib84","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection","volume":"41","author":"Cammarota","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2024.101924_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103034","article-title":"The role of faecal microbiota transplantation in chronic noncommunicable disorders","volume":"141","author":"Mullish","year":"2023","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib86","article-title":"Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.bpg.2024.101924_bib87","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.29646","article-title":"Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis","volume":"67","author":"Garc\u00eda-Lezana","year":"2018","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.bpg.2024.101924_bib88","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101924_bib89","first-page":"12","article-title":"Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: a randomized clinical trial","volume":"4","author":"Xue","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bpg.2024.101924_bib90","doi-asserted-by":"crossref","first-page":"759306","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"issue":"13","key":"10.1016\/j.bpg.2024.101924_bib91","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.3390\/nu15133039","article-title":"Effect of a Probiotic and a Synbiotic on Body Fat Mass, Body Weight and Traits of Metabolic Syndrome in Individuals with Abdominal Overweight: A Human, Double-Blind, Randomised, Controlled Clinical Study","volume":"15","author":"Laue","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib92","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41467-022-29968-0","article-title":"A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bpg.2024.101924_bib93","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cmet.2022.12.001","article-title":"Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial","volume":"35","author":"Ezpeleta","year":"2023","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.bpg.2024.101924_bib94","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.cmet.2023.08.002","article-title":"Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations","volume":"35","author":"Ni","year":"2023","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.bpg.2024.101924_bib95","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1111\/1750-3841.15367","article-title":"Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial","volume":"85","author":"Behrouz","year":"2020","journal-title":"J Food Sci"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691824000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691824000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:04:01Z","timestamp":1778616241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691824000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":95,"alternative-id":["S1521691824000490"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2024.101924","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2024.101924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101924"}}